Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Maze Therapeutics logo

Maze Therapeutics

Recent Finacing

Series D

Recent Raise

$115M

Maze Therapeutics uses human genetics, data science and functional genomics through Compass platform to discover and develop small-molecule and biologic therapies for genetically defined renal, metabolic and neurologic diseases.

Founded 2017
California, United States
101-250
Publicly Traded
mazetx.com
PitchBook

Highlights

Focus Areas

Biopharma
Biotechnology
Genetics
Therapeutics

Recent Investors

Foresite Capital logo
Third Rock Ventures logo
Casdin Capital logo
ARCH Venture Partners logo
Google Ventures logo
Alexandria Venture Investments logo
N
a16z Bio + Health logo
General Catalyst logo
Matrix Capital Management logo
Terra Magnum Capital Partners logo
Moore Strategic Ventures logo

Financials

$496M

Total Raised

3

Funding rounds

19

Investors


Team

Upgrade to view the team

See the team members at Maze Therapeutics.